From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 1,814,653 shares, representing 3.1% for $49.99 million under the buyback announced on October 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.03 USD | -0.96% | -3.68% | -10.12% |
30/04 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
30/04 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.12% | 1.66B | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Tranche Update on Harmony Biosciences Holdings, Inc.'s Equity Buyback Plan announced on October 31, 2023.